Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01031
|
|||||
| Drug Name |
Methyclothiazide
|
|||||
| Synonyms |
(+-)-6-Chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-,1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxid;2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide; 6-Chloro-3-(chloromethyl)-2-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2H-1,2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3-chloromethyl-2-methyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1; Aquaresen; Aquatensen; Ciba 7272-Su; Duretic; Enduron; Enduron (TN); Enduronum; METHYLCLOTHIAZIDE; Methychlothiazide; Methyclothiazid; Methyclothiazide (JAN/USP/INN); Methyclothiazide [USAN:INN:BAN:JAN]; Methyclothiazidum [INN-Latin]; Methyclothiazidum;Methycyclothiazide; Methylchlorothiazide; Methylcyclothiazide; Meticlotiazida; Meticlotiazida [INN-Spanish]; Meticlotiazide; Meticlotiazide [DCIT]; Naturon; Naturon (VAN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C9H11Cl2N3O4S2
|
|||||
| Canonical SMILES |
CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl
|
|||||
| InChI |
InChI=1S/C9H11Cl2N3O4S2/c1-14-9(4-10)13-6-2-5(11)7(19(12,15)16)3-8(6)20(14,17)18/h2-3,9,13H,4H2,1H3,(H2,12,15,16)
|
|||||
| InChIKey |
CESYKOGBSMNBPD-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 135-07-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 360.2 | Topological Polar Surface Area | 126 | ||
| Heavy Atom Count | 20 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
1.4
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103589729
, 103828421
, 104305488
, 117629236
, 118318253
, 121362163
, 125340315
, 126635385
, 126688034
, 127614438
, 131297977
, 134224592
, 134338032
, 134975247
, 142047553
, 144076271
, 144206003
, 14828250
, 152035884
, 160963580
, 162176790
, 164178067
, 164828036
, 165704255
, 170465243
, 175611310
, 178103809
, 179116782
, 187072630
, 196108292
, 206246062
, 210279731
, 210282054
, 222395
, 223383082
, 29223229
, 409140
, 46509197
, 48416272
, 49890374
, 50112700
, 50180352
, 5184378
, 57322154
, 7847722
, 7979941
, 8152586
, 92764517
, 93619688
, 9967
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.